# Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma

> **NCT00245011** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 11 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** ifosfamide
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** Sm-EDTMP (low dose)
- **RADIATION:** sm-EDTMP (higher dose)

## Key facts

- **NCT ID:** NCT00245011
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-10
- **Final completion:** 2009-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245011, "Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00245011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*